Literature DB >> 28480667

Letter to the Editor: Central Nervous System Involvement in Relapsing Polychondritis, a Rare and Difficult Diagnosis: a Case Report.

Julien Le Marec1, Stéphanie Jobard2, Adrien Bigot2, Benjamin Terrier3, Jean Philippe Cottier4, Frédéric Bastides5, Elisabeth Diot2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28480667      PMCID： PMC5426233          DOI： 10.3346/jkms.2017.32.6.1048

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN： 1011-8934            Impact factor:   2.153


× No keyword cloud information.
  5 in total

Review 1.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

Review 2.  Tuberculous meningitis: advances in diagnosis and treatment.

Authors:  M E Török
Journal:  Br Med Bull       Date:  2015-02-18       Impact factor: 4.291

3.  Intramuscular methotrexate-induced aseptic meningitis.

Authors:  John Hawboldt; Mazen Bader
Journal:  Ann Pharmacother       Date:  2007-09-18       Impact factor: 3.154

Review 4.  Biotherapies in large vessel vasculitis.

Authors:  Y Ferfar; T Mirault; A C Desbois; C Comarmond; E Messas; L Savey; F Domont; P Cacoub; D Saadoun
Journal:  Autoimmun Rev       Date:  2016-02-12       Impact factor: 9.754

5.  Relapsing Polychondritis with Central Nervous System Involvement: Experience of Three Different Cases in a Single Center.

Authors:  Chan Hong Jeon
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153
  5 in total
  1 in total

1.  Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients.

Authors:  Xiaoyu Cao; Lixiu Zhu; Huijuan Li; Li Jiang; Dong Xu; Jiuliang Zhao; Jiaxin Zhou; Fengchun Zhang; Yong Hou; Xiaofeng Zeng
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.